Quick Answer
Senti Biosciences Holdings, Inc. reported Net Income of -$61.44 million for fiscal year 2025.
Senti Biosciences Holdings, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$61.44M | -16.4% |
| 2024 | -$52.79M | +25.7% |
| 2023 | -$71.06M | -22.1% |
| 2022 | -$58.21M | -5.2% |
| 2021 | -$55.32M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$18.13M | +37.2% | -23.0% |
| June 30, 2025 | -$14.73M | -31.5% | -4.4% |
| March 31, 2025 | -$14.11M | -16.5% | +51.1% |
| September 30, 2024 | -$28.87M | -93.4% | -157.7% |
| June 30, 2024 | -$11.20M | +40.1% | +7.5% |
| March 31, 2024 | -$12.11M | +35.3% | +18.8% |
| September 30, 2023 | -$14.92M | +10.3% | +20.2% |
| June 30, 2023 | -$18.70M | -61.9% | +0.1% |
- Senti Biosciences Holdings, Inc. showed a decrease of -16.4% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, Senti Biosciences Holdings, Inc.’s net income has declined by 11.1% (from -$55.32 million to -$61.44 million).
- The most recent figure is from Senti Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: